Nearly two years after Takeda pulled its US marketing application for a vaccine against dengue fever, MSD has advanced a rival shot into phase 3. The international MOBILIZE-1 trial is looking at a ...
To get access to ad-free episodes, exclusive podcasts, unlimited briefings, stories, and transcripts, and other valuable bonus features sign up today. Welcome in! You’ve entered, Only Malware in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results